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During gestation the developing human fetus is exposed to a diverse 
range of potentially immune-stimulatory molecules including semi-allogeneic 
antigens from maternal cells1,2, substances from ingested amniotic fluid3,4, 
food antigens5 and microbes6. Yet the capacity of the fetal immune system, 
including antigen presenting cells (APC), to detect and respond to such 
stimuli remains unclear. In particular, dendritic cells (DC), which are crucial 
for effective immunity and tolerance, remain poorly characterized in the 
developing fetus. Here, we show that APC subsets can be identified in fetal 
tissues and are related to adult APC populations. Similar to adult DC, fetal 
DC migrate to lymph nodes and respond to TLR ligation; however, they 
differ markedly in their response to allogeneic antigens, strongly promoting 
regulatory T cell (Treg) induction and inhibiting T cell TNF-α  production 
through arginase-2 activity. Our results reveal a previously unappreciated 
role of DC within the developing fetus and indicate that fetal DC mediate 
homeostatic immune suppressive responses during gestation. 
 
 We employed a combination of flow cytometry and gene array analysis to 
characterize human fetal APC and compare them with adult APC. Using our 
previously-described gating strategy for adult tissue APC7,8 (Extended Data Fig. 
1a, b), we identified fetal APC subsets: CD14+ monocytes/macrophages, pDC, 
cDC1 and cDC2 within fetal spleen, skin (in agreement with findings from 
others9), thymus and lung (Fig. 1a and Extended Data Fig. 1a) by 13 weeks (wk) 
estimated gestational age (EGA). Within both early (12-15wk) and late (16-22wk) 
2nd trimester fetal tissues, APC were relatively abundant within the CD45+ 
compartment in comparison with equivalent adult tissues (Fig. 1b, Extended Data 
Fig. 1c). Fetal spleen cDC1 and cDC2 were also observed in situ using 
immunofluorescence microscopy (Extended Data Fig. 1d). Next we compared 
the gene expression profiles of cDC1, cDC2 and CD14+ cells purified by FACS 
from fetal skin and spleen with those from adult spleen (for sort gating strategy see 
Extended Data Fig. 1a, b and post-sort cell purity confirmation Extended Data 
Fig. 2a) as well as with published data on adult blood- and skin- derived APC 
subsets (Supplemental Experimental Procedures, Extended Data Fig. 3 and7). 
Connectivity map (CMAP) analysis7 was performed to compare the subset-
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specific gene expression signatures of fetal spleen and skin cDC1, cDC2 and 
CD14+ cells with adult blood, skin and spleen APC (Fig. 1c). CMAP scores 
indicated that gene expression signature of fetal cDC1 was enriched with genes 
also expressed by adult cDC1; similarly, the fetal cDC2 signature was enriched 
with adult cDC2-associated genes and fetal CD14+ cells scored most highly with 
adult blood monocyte and tissue macrophage populations, as expected7,8. Scatter 
plot analysis of normalized gene expression confirmed the strong correlation (R 
score 0.92) between the expression profiles of fetal and adult cDC1, as well as 
fetal and adult cDC2 (Extended Data Fig. 2b). Conserved gene lists across fetal 
and adult APC subsets and Ingenuity Pathway Analysis (IPA) of these gene lists 
are provided in SI Tables 1 - 9 (See Supplementary Experimental Procedures 
for the analysis). At the molecular level, fetal and adult DC expressed comparable 
levels of DC subset-specific transcription factors such as IRF8, IRF4, BATF3 and 
CADM1 (Extended Data Fig. 2c), in agreement with published data10. Detailed 
phenotyping of fetal and adult spleen DC by CyTOF and OneSense analysis (see 
Supplemental Experimental Procedures and11) demonstrated that fetal and adult 
spleen DC had similar antigen expression profiles, except for CD141, FcεR1 and 
CLA which were relatively more highly expressed on adult cDC2 (Extended Data 
Fig. 4a, b).  
 
To gain insight into the functions and heterogeneity of the fetal tissue cDC 
populations, we first compared their surface antigen expression profiles across 
tissues within single donors (Fig. 2a, input gating strategy and original heatmap in 
Extended Data Fig. 5a, b), and with cDC from adult tissues using CyTOF and 
OneSense analysis11 (Extended Data Fig. 5c). Fetal cDC1 and cDC2 showed 
great heterogeneity between tissues at the single cell level (Fig. 2a), most 
obviously within the lung, suggesting differential tissue imprinting. We also 
identified tissue-specific cDC phenotypes conserved between adults and fetuses 
(Extended Data Fig. 5c).  For example, both fetal and adult lung cDC2 expressed 
elevated levels of CD2 and FcεR1, while expression of these markers by fetal and 
adult gut cDC were low to negative. Notably, the fetal lung cDC2 population 
exhibited heterogeneous expression of the transcription factor IRF4 (Extended 
Data Fig. 5d), which indicates contamination of the gated population with 
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monocytes and/or monocyte-derived cells, as seen in adults12. Several activation 
markers were differentially expressed between cDC from different fetal tissues. In 
particular, fetal gut cDC displayed a more activated phenotype than did cDC in 
others fetal tissues (Fig. 2 a and Extended Data Fig. 5b, c), expressing higher 
levels of the chemokine receptor CCR7 and the activation markers CD80 and 
CD86. As CCR7 mediates DC migration to lymph nodes in adults, where they 
initiate and shape emergent T cell responses8,13, we then asked whether CCR7+ gut 
DC migrated to their draining lymphoid organs during fetal life. Using a gating 
strategy verified in adult tissues7, we identified migratory (HLA-DRhiCD11clo/int) 
and resident (HLA-DRintCD11chi) DC in 16wk EGA fetal mesenteric lymph nodes 
(MLN) (Fig. 2b). In contrast, in the fetal appendix and tonsil, which lack 
connecting afferent lymphatics, we observed only resident DC (Fig. 2b). Within 
the MLN, the resident cell population included CD14+ cells, cDC1 (CD26+CD1c-) 
and cDC2 (CD26-CD1c+) (Extended Data Fig. 6a). The migratory-phenotype 
fraction of DC within the MLN contained relatively few CD14+ cells, as in 
adults7,8, alongside both cDC1 and cDC2, with the former relatively more 
abundant (Extended Data Fig. 6a, b). Of note fetal gut cDC1 expressed more 
CCR7 than did cDC2 (Extended Data Fig. 5c), which might suggest preferential 
priming and greater migratory capacity within this population. Similar to adult 
migratory DC7, fetal MLN migratory DC expressed higher levels of CCR7 and the 
activation markers CD80, CD83 and CD86 than did DC with the resident 
phenotype (Extended Data Fig. 6c). Looking along the timeline of the 2nd 
trimester of gestation, we found that while MLN from 14-15wk EGA fetuses 
contained abundant resident DC, migratory DC were scarce or absent (Fig. 2c, d), 
suggesting that fetal gut DC begin migrating to the MLN from 16-17wk EGA. The 
presence of migratory DC in the MLN is consistent with expression of the lymph 
node-homing cytokines CCL19 and CCL2114 in the fetal gut and MLN (Extended 
Data Fig. 6d, e). Migratory HLA-DR+ cells were also visualized within the 
lymphatic vessels (LYVE-1+) of 17-22wk EGA fetal skin (Extended Data Fig. 
6f), using a protocol validated in adult skin8, providing confirmation that fetal cDC 
can migrate via lymphatic vessels in vivo. Furthermore, we observed fetal DC 
actively migrating out of skin explants over a period of 48 hours (Extended Data 
Fig. 6g), using ex vivo skin assays validated in adult tissues15. In summary, our 
data suggest that fetal skin and gut DC have the capacity to migrate through 
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lymphatics and to lymph nodes from 16wk EGA, where they may interact with 
fetal T cells that are present in lymphoid organs from 10wk EGA16. The reason for 
the initiation of DC migration to the lymph nodes around 16wk EGA remains 
unclear: while the human lymphatic system is structurally complete by 8wk EGA, 
it may remain functionally immature for some time thereafter17.  
 
Next, we asked whether fetal cDC were able to respond to ligation of their 
toll-like receptors (TLR)18 and/or to stimulate naïve T cells in vitro. We sorted the 
most abundant cDC subset, splenic cDC2, from 17-22wk EGA fetuses and adult 
samples and exposed them to a panel of TLR agonists: adult and fetal cells 
secreted similar amounts of the pro-inflammatory cytokines GM-CSF, IL-6, IL-8 
and MIP-1β (Fig. 3a, Extended Data Fig. 7a), in line with their similar 
expression of pattern recognition receptors (Extended Data Fig. 7b). Moreover, 
fetal and adult splenic cDC2 induced comparable proliferation of allogeneic 
CFSE-labeled adult splenic T cells in a mixed lymphocyte reaction (MLR) (Fig. 
3b). Thus fetal cDC are capable of both sensing pathogens and stimulating T cells, 
which, together with their migratory ability, indicates that they have the potential 
to initiate an immune response to microbe-derived products around 17wk EGA.  
 
While this shows that fetal cDC are capable of initiating allogeneic T cell 
proliferation in vitro, we know that life-long in vivo tolerance towards non-
inherited maternal allogeneic antigens is established during gestation2,9,19Thus, to 
understand how fetal DC contribute to such tolerogenic T cell responses, we 
examined the phenotype of the T cell populations generated from MLR, where 
fetal or adult cDC2 were co-cultured with allogeneic adult spleen T cells. After 6 
days co-culture, fetal spleen cDC2 induced the differentiation of significantly 
higher frequencies of CD4+CD25+FOXP3+CD127-CTLA4+ bona fide T regulatory 
cells (Treg)1,20,21 than did adult splenic cDC2 (Extended Data Fig. 8 a, b, c). 
Confirming the immunosuppressive capacity of fetal cDC2-induced Tregs, CD8+ 
T cell proliferation was significantly impaired upon co-culture with fetal cDC2 as 
opposed to adult cDC2 (Extended Data Fig. 8d), and was restored when CD4+ T 
cells were removed (Extended Data Fig. 8e). In addition, allogeneic T cells 
cultured with fetal cDC2 (Figure 4a) or cDC1 (Extended Data Fig. 8f) produced 
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significantly less of several pro-inflammatory cytokines and significantly more of 
the Th2-polarising cytokine IL-4, but not IL-13, compared with allogeneic T cells 
incubated with adult cDC2. Thus, consistent with the establishment of fetal 
tolerance to maternal antigens in vivo, fetal cDC initiate Treg induction and do not 
launch T cell pro-inflammatory responses in vitro. 
 
The observed functional differences between fetal and adult DC were 
mirrored at their gene expression level, with over 3,000 genes being significantly 
differentially expressed between fetal and adult APC (Fig. 9a, SI Table 10, 11). 
IPA revealed that multiple pathways involved in educating T cells were 
significantly differentially regulated between fetal and adult APC, as were several 
pathways involved in the iNOS/TNF-α axis (Extended Data Fig. 9b,  red and 
black arrows, respectively, SI Table 12). Further analysis revealed that a number 
of genes involved in immune-suppression/inflammation were differentially 
expressed (Extended Data Fig 9c). Of particular interest was the elevated 
expression of arginase-2 by fetal spleen cDC2 (Fig. 4b, c) and cDC1 (Extended 
Data Fig. 9d, e) in comparison with adult spleen cDC. Of note, arginase 2 
expression was not modulated by TLR stimulation (Extended Data Fig. 9f). 
Arginase depletes the local environment of L-arginine (by converting L-arginine 
to L-ornithine and urea) which is required for the production of TNF-α22,23. 
Importantly, arginase activity has been shown to be an essential player in the 
regulation of TNF-α levels in the neonate22.  
 
Coincidingly, we found that in stimulated splenic culture (i.e. include 
APC), fetal T cells did not produced TNF-α compared to adult T cells (Fig. 4d, 
Extended Data Fig. 10a). However, when enriched (i.e. in the absence of APC), 
they produced TNF-α, although to a lesser level to their adult counterparts (Fig. 
4d). Furthermore, we found significantly lower frequencies of fetal T cells 
producing TNF-α than adult T cells after 6 days of culture (Extended Data Fig. 
10b). In addition, when fetal and adult splenocytes were co-cultured at increasing 
ratios of fetal cells, adult T cell TNF-α production was impaired. While fetal 
splenocytes also promoted Treg induction, the change in TNF-α levels did not 
correlate with the change observed in Treg induction (Extended Data Fig. 10b-d).  
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These data suggested that the differential arginase-2 expression between adult and 
fetal cDC is sufficient to regulate T cell responses and their TNF-α production.  
 
In the absence of any cDC, approximately 24% of proliferating adult 
splenic T cells produced TNF-α, while following 6 days co-culture with fetal 
cDC2 (Fig. 4e, f) or cDC1 (Extended Data Fig. 9g) that express arginase-2, their 
ability to produce TNF-α was dramatically reduced. TNF-α production was 
reinstated upon replenishing the medium with L-arginine or by the addition of 
arginase-specific inhibitors22 (Fig. 4e, f), confirming that the reduced TNF-α 
production was mediated through arginase-2 activity. Treg numbers did not 
change when arginase activity was modulated, suggesting fetal DC regulation of 
TNF-α production is independent of their promotion of Treg induction (Extended 
Data Fig. S10e-h). Further analysis of the supernatants from the co-cultures found 
that fetal cDC did not mediate T cell production of other pro-inflammatory 
cytokines by arginase activity (Extended Data Fig. 10i-k), suggesting fetal DC 
utilize a range of mechanisms to regulate T cell biology which remain to be 
explored. We also found that when fetal cDC were cultured with adult cDC2, they 
could abrogate adult cDC2 promotion of TNF-α production by T cells (Extended 
Data Fig. 10l, m). In addition, when fetal T cells were cultured in the absence of 
cDC, they produced TNF-α, but when co-cultured with fetal cDC their ability to 
produce TNF-α was significantly impaired (Fig. 4g). Altogether, these data 
confirm that in the absence of TLR stimulation, fetal DC promote immune-
suppression and impair T cell TNF-α production in response to allogeneic 
antigens through expression of arginase-2. Importantly, a recent study highlighted 
the crucial role of L-arginine as major modulator of adult T cell biology24.  
 
In summary, our findings uncovered a yet unknown mechanism of 
tolerance and immune suppression that is used during gestation by fetal cDC and 
works in concert with others mechanisms used by fetal NK cells25 and Tregs1. 
Understanding the mechanisms through which TNF-α production is regulated 
within the fetus is important as elevated levels of TNF-α are associated with a 
number of pregnancy and perinatal complications including recurrent spontaneous 
miscarriage, gestational diabetes and necrotizing enterocolitis. Our data suggest 
	 9	
that the regulation of L-arginine levels by fetal DC is important for controlling T 
cell TNF-α levels during gestation placing fetal DC are key regulators of TNF-α 
production and should be investigated as potential therapeutic target in such 
situations. In addition, our study demonstrates that fetal cDC are immunologically 
dynamic and can orchestrate immune responses as early as in the 2nd trimester. 
How TLR stimulation during intrauterine infections can override immune-
suppression induced by arginase 2 expressing fetal DC in an allogeneic context 
remain to be explored. Altogether, these findings highlight that key processes in 
human immune development and programming in fact begin early during 
gestation and may have life-long implications for immune homeostasis19.  
 
Acknowledgements 
This work was supported by Singapore Immunology Network core (F.G and 
E.W.N), BMRC YIG (N.McG), Austrian Science Fund (P19474-B13, W1248-
B30 to A.E-B), BMRC SPF2014/00 (S.A.), and the Singapore Ministry of 
Health’s National Medical Research Council (J.K.Y.C, CSIRG/1383/2014). We 
thank Dr L. Robinson of Insight Editing London for manuscript editing. 
 
Author Contributions 
Conceptualization, N.McG., F.G., J.K.Y.C.; Methodology, N.McG., A.S., G.L., 
D.L., L.J.T., R.M, I.L., N.B.S., H.R.S., E.S., J.L., E.M., S.H., P.S., B.J., C.S., A.E-
B., X.N.W, E.W.N; Clinicians for helping to access samples and discussion,.  
E.H.K., Y.H.L., M.C., C.N.Z.M., Y.F., T.K.H.L., D.K.H, K-K.T., J.K.C.T., V.B, 
M.C, M.H, A.S, S.A, A.L, E.W.N; Bioinformatic analysis, N.McG., K.D., M.P., 
F.G.; Writing, N.McG., F.G., J.K.Y.C . 
 
 
 
 
 
 
 
 
	 10	
References 
 
1. Mold, J. E. et al. Maternal alloantigens promote the development of 
tolerogenic fetal regulatory T cells in utero. Science 322, 1562–1565 
(2008). 
2. Claas, F. H., Gijbels, Y., van der Velden-de Munck, J. & van Rood, J. J. 
Induction of B cell unresponsiveness to noninherited maternal HLA 
antigens during fetal life. Science 241, 1815–1817 (1988). 
3. de Vries, J. I., Visser, G. H. & Prechtl, H. F. The emergence of fetal 
behaviour. II. Quantitative aspects. Early Hum. Dev. 12, 99–120 (1985). 
4. Mor, G. & Cardenas, I. The immune system in pregnancy: a unique 
complexity. Am. J. Reprod. Immunol. 63, 425–433 (2010). 
5. Campbell, D. E., Boyle, R. J., Thornton, C. A. & Prescott, S. L. 
Mechanisms of allergic disease - environmental and genetic determinants 
for the development of allergy. Clin. Exp. Allergy 45, 844–858 (2015). 
6. Aagaard, K. et al. The placenta harbors a unique microbiome. Sci Transl 
Med 6, 237ra65–237ra65 (2014). 
7. Haniffa, M. et al. Human tissues contain CD141hi cross-presenting 
dendritic cells with functional homology to mouse CD103+ nonlymphoid 
dendritic cells. Immunity 37, 60–73 (2012). 
8. McGovern, N. et al. Human Dermal CD14(+) Cells Are a Transient 
Population of Monocyte-Derived Macrophages. Immunity 41, 465–477 
(2014). 
9. Schuster, C. et al. HLA-DR+ leukocytes acquire CD1 antigens in 
embryonic and fetal human skin and contain functional antigen-presenting 
cells. Journal of Experimental Medicine 206, 169–181 (2009). 
10. Schlitzer, A., McGovern, N. & Ginhoux, F. Dendritic cells and monocyte-
derived cells: Two complementary and integrated functional systems. 
Semin. Cell Dev. Biol. 41, 9–22 (2015). 
11. Cheng, Y., Wong, M. T., van der Maaten, L. & Newell, E. W. Categorical 
Analysis of Human T Cell Heterogeneity with One-Dimensional Soli-
Expression by Nonlinear Stochastic Embedding. The Journal of 
Immunology 196, 924–932 (2016). 
12. Guilliams, M. et al. Unsupervised High-Dimensional Analysis Aligns 
Dendritic Cells across Tissues and Species. Immunity 45, 669–684 (2016). 
13. Ohl, L. et al. CCR7 governs skin dendritic cell migration under 
inflammatory and steady-state conditions. Immunity 21, 279–288 (2004). 
14. Förster, R., Davalos-Misslitz, A. C. & Rot, A. CCR7 and its ligands: 
balancing immunity and tolerance. Nat Rev Immunol. 8, 362–371 (2008). 
15. Wang, X.-N. et al. A Three-Dimensional Atlas of Human Dermal 
Leukocytes, Lymphatics, and Blood Vessels. J Investig Dermatol (2013). 
doi:10.1038/jid.2013.481 
16. Haynes, B. F. & Heinly, C. S. Early human T cell development: analysis of 
the human thymus at the time of initial entry of hematopoietic stem cells 
into the fetal thymic microenvironment. The Journal of Experimental 
Medicine 181, 1445–1458 (1995). 
17. Schuster, C. et al. Development of Blood and Lymphatic Endothelial Cells 
in Embryonic and Fetal Human Skin. The American journal of pathology 
185, 2563–2574 (2015). 
18. Tong, X. Amniotic fluid may act as a transporting pathway for signaling 
	 11	
molecules and stem cells during the embryonic development of amniotes. J 
Chin Med Assoc 76, 606–610 (2013). 
19. Burlingham, W. J. et al. The effect of tolerance to noninherited maternal 
HLA antigens on the survival of renal transplants from sibling donors. N. 
Engl. J. Med. 339, 1657–1664 (1998). 
20. Liu, W. et al. CD127 expression inversely correlates with FoxP3 and 
suppressive function of human CD4+ T reg cells. The Journal of 
Experimental Medicine 203, 1701–1711 (2006). 
21. Seddiki, N. et al. Expression of interleukin (IL)-2 and IL-7 receptors 
discriminates between human regulatory and activated T cells. The Journal 
of Experimental Medicine 203, 1693–1700 (2006). 
22. Elahi, S. et al. Immunosuppressive CD71+ erythroid cells compromise 
neonatal host defence against infection. Nature 504, 158–162 (2013). 
23. Morris, S. M. Arginine: master and commander in innate immune 
responses. Sci Signal 3, pe27 (2010). 
24. Geiger, R. et al. L-Arginine Modulates T Cell Metabolism and Enhances 
Survival and Anti-tumor Activity. Cell 167, 829–842.e13 (2016). 
25. Ivarsson, M. A. et al. Differentiation and functional regulation of human 
fetal NK cells. The Journal of Clinical Investigation 123, 3889–3901 
(2013). 
26. J, P. Review of the guidance on the research use of fetuses and fetal 
material. (1989). 
27. Schlitzer, A. et al. IRF4 transcription factor-dependent CD11b+ dendritic 
cells in human and mouse control mucosal IL-17 cytokine responses. 
Immunity 38, 970–983 (2013). 
28. Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N. & Golani, I. Controlling the 
false discovery rate in behavior genetics research. Behav. Brain Res. 125, 
279–284 (2001). 
29. Breitling, R., Armengaud, P., Amtmann, A. & Herzyk, P. Rank products: a 
simple, yet powerful, new method to detect differentially regulated genes in 
replicated microarray experiments. FEBS Lett. 573, 83–92 (2004). 
 
 
 
 
Figure legends  
 
Figure 1. Identification of fetal APC. a, CD14+ cells, cDC1 and cDC2 were 
identified within fetal spleen and skin by flow cytometry. b, Enumeration of APC 
subsets within fetal and adult tissues. Mann-Whitney test *P<0.05, **P<0.01, 
***P<0.001. Mean±s.e.m.c, CMAP enrichment scores for fetal skin and spleen 
cDC1, cDC2 and CD14+ cells against all adult blood, skin and spleen APC subsets 
are shown. Enrichment scores for fetal skin and spleen cDC1, cDC2 and 
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CD14+cells with equivalent adult APC subsets were significant at P<0.0001. a, b 
Each data point in the scatter plots represents an individual experiment. 
 
Figure 2. Fetal cDC migrate to draining lymph nodes. a, Characterisation of 
cDC1 and cDC2 across fetal tissues using CyTOF and one-Sense algorithm  (see 
Methods, representative plots of n=5). b, c Flow cytometry analysis of fetal 
mesenteric lymph nodes (MLN) at 16wk (b) or 14wk (c) EGA. Within the HLA-
DR+Lin- gate (black), MLN- HLA-DRintCD11chi resident DC (pink) are 
distinguished from HLA-DRhiCD11int migratory DC (orange gate). b, 16wk EGA 
MLN (left) and fetal appendix and tonsil (right, n=3). d, Enumeration of migratory 
cDC at indicated time points. Mean±s.e.m. Each data point in the scatter plots 
represents an individual experiment.  
 
Figure 3. Fetal cDC are responsive to TLR stimulation and induce T cell 
proliferation. a, Cytokines in supernatants of fetal and adult cDC2 stimulated for 
18 hrs with TLR agonists; CL075 (1µg/ml), CPG (3µM), PI:C (25µg/ml), PGN 
(10µg/ml), LPS (0.1µg/ml)+CD40L (1µg/ml). Mean±s.e.m, n=4. b, Alloactivation 
of adult CD4+ T cells by fetal and adult cDC2 after 6 days co-culture. Proliferation 
was measured by CFSE dilution. Left panel, representative histograms. Right bar 
graph, cumulative data, n=5. Data shown as mean±s.e.m. ns, not significant 
(P>0.05), Mann-Whitney test. 
 
Figure 4. Arginase 2+ fetal cDC regulate TNF-α  production. a, Cytokine 
production by adult T cells after 6 days co-culture with fetal or adult cDC2 (n=5). 
b, c Expression of arginase-2 gene (b) and protein (c) in cDC2. d, Splenocyte T 
cell TNF-α production. e, f TNF-α production (red) of stimulated adult T cells, 
after overnight culture in the absence (Day 0) or presence of cDC2 (Day 6 of co-
culture), with or without additional supplementation of L-arginine or arginase 
inhibitors (ABH or BEC). e, Representative dot plots. f, Cumulative data. g, TNF-
α production from stimulated fetal T cells under indicated culture conditions. Data 
shown as mean±s.e.m. *p<0.05, **p<0.01, ***P<0.001, Mann-Whitney test. Each 
data point in the scatter plots represents an individual experiment. 
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Supplementary Experimental Procedures 
 
Human samples and consent 
The donation of fetal tissue for research is approved by the Centralised 
Institutional Research Board (CIRB) of the Singapore Health Services in 
Singapore. This approval strictly follows established international guidelines 
regarding the use of fetal tissue for research26. This approval allowed the 
collection of fetal tissue from women undergoing clinically-indicated termination 
of pregnancies for the study of immune cells in different fetal tissues. Women 
gave written informed consent for the donation of fetal tissue to research nurses 
who were not directly involved in the research, or in the clinical treatments of 
women participating in the study as per the Polkinghorne guidelines26. This 
protocol has been reviewed on an annual basis by the CIRB that includes annual 
monitoring of any adverse events, for which there had been none.  All fetal organs 
for this study (lung, thymus, spleen, mesenteric lymph nodes, gut, appendix, liver, 
tonsil and skin) were obtained from 2nd trimester (12-22 wk EGA). All fetuses 
were considered structurally normal on ultrasound examination prior to 
termination and by gross morphological examination following termination. In 
total 72 fetuses of 14-16 wk EGA and 24 fetuses of 17-22 wk EGA were used for 
this study. For comparisons across fetal organs the same donors were used, for 
example for CyTOF data analysis. 
Adult tissue (lung, spleen, gut and skin) were obtained with approval from 
Singapore Singhealth and National Health Care Group Research Ethics 
Committees. 
 
Cell isolation 
Fetal organs were mechanically dispersed and incubated with 0.2 mg/ml 
collagenase (Type IV; Sigma Aldrich) and DNase I (20000U/ml, Roche) in RPMI 
with 10% FCS for up to 1 hour in a 6 well plate. Viability was typically 80-90% 
measured by DAPI exclusion (Partec). Fetal gut was initially cut longitudinally 
through the center, washed extensively in PBS until all inner content (meconium) 
was removed and the PBS was clear, before mechanical dispersion and digestion 
as above, for up to 1h. Adult lung specimens (8 samples from different donors) 
were obtained from peritumoral tissue. Adult skin (20 samples from different 
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donors) was obtained from mammoplasty and breast reconstruction surgery. Adult 
spleen specimens (8 samples from different donors) were obtained at distal 
pancreatectomies in patients with pancreatic tumours in the pancreas. Adult lung27 
and skin8 specimens were prepared as described previously. Adult spleen 
specimens were prepared in a similar manner to lung. Tissue macrophages and DC 
were isolated to 95% purity from freshly digested tissue cell suspensions by 
fluorescence activated cell sorting (FACS) using BD FACSAriaII or III (BD 
Biosciences). T cells were isolated to 90% purity from adult and fetal spleen by 
negative selection using T cell enrichment kits (Miltenyi Biotec) and separated on 
an AutoMacs following manufacturer’s instructions. T cells were labeled with 
0.2µM carboxyfluorescein succinimidyl ester (CFSE) (Life Technologies) for 5 
minutes at 37°C. In all experiments enriched APC and T cells were from fetal and 
adult spleen unless stated otherwise. 
 
Flow cytometry 
Flow cytometry was performed on a BDLSRII and data analyzed with FlowJo 
(Treestar). Antibodies used are listed in Table 12. The eBioscience FOXP3 / 
Transcription Factor Staining Buffer Set (eBioscience/Affimetrix) was used for 
intracellular staining of IRF8, IRF4, CTLA4, arginase-2, TNF-α and FOXP3 cells 
by following manufacturer’s instructions. ALDEFLUORTM kit (STEMCELL 
technologies) was used to measure ALDH activity. 
 
Mixed lymphocyte reactions 
5,000 sorted cDC from defined subpopulations were co-cultured with 100,000 
CFSE-labeled adult or fetal spleen T cells for 6 days in 200µl complete RPMI-
1640 GlutamaxTM medium (Life Technologies) supplemented with 10% FBS and 
1% penicillin/streptomycin27. On day 6, cells supernatants (100µl) were removed 
and stored at -80oC for detection of the cytokines indicated in Fig. 4a, Extended 
Data Fig. 8f, 10h-j) at a later date. Cytokines were detected using Luminex® 
bead-based multiplex assays, as detailed below. For analysis of intracellular TNF-
α production analysis, on day 6 of co-cultures T cells were re-stimulated with 
10µg/ml phorbol myristate acetate (PMA) and 500 µg/ml Ionomycin for 1 hour at 
37°C. 10 µg/ml Brefeldin A solution was added for 4 hours. Intracellular cytokine 
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production was determined by flow cytometry. In some experiments on Day 0, the 
arginase inhibitors S-(2-boronoethyl)-l-cysteine (BEC) or amino-2-borono-6-
hexanoic acid (ABH) (each used at 30µM respectively) were added to co-cultures. 
In some experiments on Day 6, 1 mM l-arginine was added to co-cultures 1 hour 
prior to stimulation with PMA/Ionomycin. 
 
Ex-vivo co-culture assays 
Fetal or adult splenocytes (1x105) were seeded into 96-well round bottom plates 
alone or combined at defined ratios in 200µl medium. After o/n or 6 days of co-
culture the splenocytes were stimulated with 10 µg/ml phorbol myristate acetate 
(PMA) (InvivoGen) and 500 µg/ml Ionomycin (Sigma) for 1 hour at 37°C. 10 
µg/ml Brefeldin A solution was added for 4 hours. Intracellular T cell TNF-α 
production was determined by flow cytometry as described above. 
 
Millipore Luminex® bead-based multiplex assays on supernatants from 
mixed lymphocyte reactions 
Samples (supernatants) or standards were incubated with fluorescent-coded 
magnetic beads pre-coated with cytokine-specific capture antibodies. After an 
overnight incubation at 4°C with shaking, plates were washed twice with wash 
buffer. Biotinylated detection antibodies specific to the cytokine of interest were 
incubated with the complex for 1 hour and subsequently Streptavidin-PE was 
added and incubated for another 30 minutes. Plates were washed twice again, and 
beads were re-suspended with sheath fluid before a minimum of 50 beads per 
cytokine were analysed on the Luminex FLEXMAP® 3D (Merck Millipore). Data 
acquisition was carried out using xPONENT® 4.0 (Luminex) acquisition software, 
with data analysed in Bio-Plex Manager® 6.1.1 (Bio-Rad). Cytokine 
concentrations were calculated from the standard curve using a 5PL (5-parameter 
logistic) curve fit. 
 
Drop array Luminex assays on fetal and adult spleen cDC2 
Sorted fetal (17-22wk EGA) and adult spleen cDC2 were incubated for 18 hours at 
20,000 cells/well in 100µl complete RPMI-1640 GlutamaxTM medium (Life 
Technologies) supplemented with 10% FBS and 1% penicillin/streptomycin, and 
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stimulated with either TLR agonists; CL075 (1µg/ml), CPG (3µM), PI:C 
(25µg/ml), PGN (10µg/ml), LPS (0.1µg/ml) + CD40L (1µg/ml), or DMSO 
control. Cells were then pelleted and 95µl of supernatants were collected. Fetal 
and adult spleen cDC2 cytokine production was assessed using Luminex® bead-
based multiplex assays. Cytokines indicated in the figures were detected with 
DropArrayTM-bead plates (Curiox) according to manufacturers’ recommendations. 
Acquisition was performed with the xPONENT 4.0 (Luminex) acquisition 
software, while data analysis was performed with Bio-Plex Manager 6.1.1 (Bio-
Rad). 
 
Mass cytometry staining, barcoding, acquisition and data pre-processing 
For mass cytometry analysis, purified antibodies were obtained from Invitrogen, 
Fluidigm, Biolegend, eBioscience, Beckton Dickinson and R&D Systems using 
clones as listed in SI Table 13. For some markers, fluorophore- or biotin-
conjugated antibodies were used as primary antibodies, followed by secondary 
labeling with anti-fluorophore metal-conjugated antibodies (i.e. anti-FITC clone 
FIT-22) or metal conjugated streptavidin produced as previously described11. 
Briefly, cells were plated, stained, and labeled in a V-bottom 96 well plate (BD 
Falcon). Cells were washed once with 200µl FACS buffer (4% FBS, 2mM EDTA, 
0.05% Azide in 1X PBS), followed by staining with 100µl of 200µM cisplatin 
(Sigma-Aldrich) for 5 minutes on ice to exclude dead cells. Cells were then 
labelled with anti-CADM1-biotin and antibodies in a 50µl reaction volume for 30 
minutes on ice. Cells were washed twice with FACS buffer and labeled with 50µl 
heavy-metal isotope-conjugated secondary antibody cocktail for 30 minutes on 
ice. Cells were washed twice with FACS buffer then once with PBS before 
fixation with 200µl 2% PFA (Electron Microscopy Sciences) in PBS overnight or 
longer. Following fixation, cells were pelleted and resuspended in 200µl 1X perm 
buffer (Biolegend) and allowed to stand for 5 minutes at room temperature. Cells 
were washed once with PBS before barcoding. Bromoacetamidobenzyl-EDTA 
(BABE)-linked metal barcodes were prepared by dissolving BABE (Dojindo) in 
100mM HEPES buffer (Gibco) to a final concentration of 2mM. Then 
isotopically-purified PdCl2  (Trace Sciences Inc.) was added to BABE solution to 
0.5mM. Similarly, DOTA-maleimide (DM)-linked metal barcodes were prepared 
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by dissolving DM (Macrocyclics) in L buffer (MAXPAR) to a final concentration 
of 1mM. Then, 50mM of RhCl3 (Sigma) and isotopically-purified LnCl3 were 
added to DM solution to 0.5mM. Six metal barcodes were used: BABE-Pd-102, 
BABE-Pd-104, BABE-Pd-106, BABE-Pd-108, BABE-Pd-110 and DM-Ln-113. 
All BABE and DM-metal solution mixtures were immediately snap-frozen in 
liquid nitrogen and stored at -80oC. A unique dual combination of barcodes was 
chosen to stain each tissue sample. Barcode Pd-102 was used at 1:4000 dilution, 
Pd-104 at 1:2000, Pd-106 and Pd-108 at 1:1000, and Pd-110 and Ln-113 at 1:500. 
Cells were incubated with 100µL of barcodes in PBS for 30 minutes on ice. Cells 
were then washed in perm buffer and incubated in FACS buffer for 10 minutes on 
ice. Cells were then pelleted and resuspended in 100µl of nucleic acid Ir-
Intercalator (MAXPAR) in 2% PFA/PBS (1:2000), at room temperature. After 20 
minutes, cells were washed twice with FACS buffer and twice with water before a 
final resuspension in water. In each set, cells were pooled from all tissue types, 
enumerated, and diluted to a final concentration of 0.5x106 cells/ml for 
acquisition. EQ Four Element Calibration Beads (DVS Science, Fluidigm) were 
added at a concentration of 1% prior to acquisition. Cells were acquired and 
analyzed using a CyTOF Mass cytometer. The data were exported in a traditional 
flow-cytometry-file (.fcs) format and cells for each barcode were deconvolved 
using Boolean gating.  
 
OneSense Analysis 
The automated analysis was performed by the OneSense algorithm as described 
previously11. For Fig. 2 and Extended Data Fig. 4b, 5b the lineage dimension 
included CD1c and SIRPα as cDC2 markers and CD26 and CLEC9A as cDC1 
markers. The marker dimension includes all the other non-lineage markers of the 
CyTOF panel. Frequency heat maps of indicated markers are displayed for both 
dimensions. cDC2 clusters (cyan gate) and cDC1 clusters (green gate) for each 
organ and their marker expression profile are highlighted by the extended gates 
(representative plots of n=5). For comparisons across fetal organs, organs from the 
same donor were used. 
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Microarray analysis  
Total RNA was isolated from FACS-purified fetal spleen and skin (17-22wk 
EGA) CD14+ cells, cDC1 and cDC2 subsets and adult spleen CD14+ cells, cDC1 
and cDC2 subsets with the Qiagen RNeasy Micro kit (Qiagen). Total RNA 
integrity was assessed using Agilent Bioanalyzer and the RNA Integrity Number 
(RIN) was calculated; all RNA samples had a RIN ≥ 7.1. Biotinylated cRNA was 
prepared according to the protocol by Epicentre TargetAmp™ 2-Round Biotin-
aRNA Amplification Kit 3.0 using 500pg of total RNA. Hybridization of cRNA 
was performed on Illumina Human-HT12 Version 4 chips. Microarray data were 
exported from GenomeStudio software without background subtraction. 
Expression values were quantile normalized and log2 transformed in R (version 
3.1.2) with Bioconductor (version 2.26.0) lumi package (version 2.18.0). For 
generation of fetal APC subset gene signatures, one cell subset was compared with 
other cell subsets pooled using t-test in R. DEGs were selected with Benjamini-
Hochberg (BH) multiple testing28 corrected p-value of < 0.05. For the adult APC 
gene expression data, samples were grouped by tissue type and tissue specific 
probes were identified with one-way ANOVA and with BH multiple testing 
corrected p-value of < 0.05. CMAP analysis as previously described11 was 
performed comparing fetal DC signature gene subsets with the adult APC gene 
expression data after removal of the tissue-specific probes (see Extended Data 
Fig. 3 for hierarchical clustering and PCA plots before and after removal of tissue 
specific probes). To identify the genes that are highly or lowly expressed in a 
particular cell subset, we used the single-class rank product method29, which is 
implemented in the Bioconductor RankProd package (version 2.38.0), and selected 
the top and bottom ranked genes with percentage of false-positives (PFP) less than 
0.01. The in-house generated adult and fetal microarray data have been submitted 
to the Gene Expression Ominous (GEO) database under the accession numbers 
GSE35457, GSE85305, and GSE85304. 
 
Quantitative real-time PCR 
Total RNA was isolated from adult or fetal gut and mesenteric lymph node (14-
20wk EGA) cells with the Qiagen RNeasy Micro kit (Qiagen). Total RNA 
integrity and concentration was assessed using nanodrop 2000 (Thermoscientific). 
Total RNA (1 µg) was reverse transcribed using oligo (dT)18 primer and 
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SuperScript II reverse transcriptase (GIBCO-BRL). CCL19 and CCL21 expression 
was analysed by Quantitative real-time PCR using the following primer: +5-
CCAGCCTCACATCACTCACACCTTGC-3 and −5-
TGTGGTGAACACTACAGCAGGCACCC-3 for CCL19; +5-
AACCAAGCTTAGGCTGCTCCATCCCA-3 and −5-
TATGGCCCTTTAGGGGTCTGTGACCG-3 for CCL21. CCL19 and CCL21 
expression was normalized to the housekeeping gene GAPDH +5-
GCCAAGGTCATCCATGACAACTTTGG-3 and −5-
GCCTGCTTCACCACCTTCTTGATGTC-3. 
 
Confocal microscopy 
Samples were prepared for confocal microscopy as described previously15. 	
Statistical analysis 
Statistical analysis used for each experiment is indicated in the figure legends. 
Each n number represents an individual donor and a separate experiment. 	
Data Availability 
Source data for figure(s) [number(s)] are provided with the paper. Sequence data 
that support the findings of this study have been deposited to the Gene Expression 
Ominous (GEO) database under the accession numbers GSE35457, GSE85305, 
and GSE85304. Further data that support the findings of this study are available 
from the corresponding author upon reasonable request.  
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Extended Data Figure Legends 
 
Extended Data Fig. 1. Identification of APC subsets in fetal and adult tissues. 
Representative flow plots of gating strategy used to identity APC subsets in fetal 
and adult tissues. a, Gating strategy used to identify APC populations within the 
live CD45+, HLA-DR+Lin- gate; CD14+ cells (red gate), pDC (pink gate), cDC1 
(blue gate) and cDC2 (green gate) in fetal lung, spleen, skin and thymus. b, Gating 
strategy used to identify CD14+ cells (red gate), pDC (pink gate), cDC1 (blue gate) 
and cDC2 (green gate) in adult lung and spleen. c, Abundance of APC plotted as a 
percentage of live CD45+ mononuclear cells. Cell abundance was determined in 
fetal lung and thymus at 2 time points within the 2nd trimester (12-15 wk EGA 
(circle, lung n=13, thymus=9) and 16-22wk EGA (square, lung n=8, thymus n=8) 
and compared with adult tissues (triangle, lung n=8). *P<0.05,  ***P<0.001, 
Mann-Whitney test. d, Pseudo-color images of whole-mount fetal spleen (17wk 
EGA) immunolabeled for CD45 (red), CD1c (blue), and CLEC9A (green). White 
arrows highlight cDC2 (CD45+CD1c+CLEC9A-), white arrow head highlights 
cDC1 (CD45+CD1c+CLEC9A+). Scale bar represents 5µm. Representative image 
of n=3 experiments shown. 
 
Extended Data Fig. 2. Comparison of the transcriptomes and phenotypes of 
fetal and adult APC subsets. a,  Confirmation of post-sort APC subset purity. 
Representative dot plots demonstrating cell purity after using FACS to isolate 
indicated APC subsets from fetal skin and spleen (18-22wk EGA), and adult 
spleen. n=4. b, Scatter plot of the log fold change in gene expression of cDC2 vs 
cDC1 from fetal and adult skin and spleen. R score = 0.92 and p-value < 2.2x10-16. 
Colors indicate genes upregulated (red) or downregulated (blue) in fetal and adult 
cDC1 relative to cDC2. c, Scatterplots demonstrating the expression profile of 
transcription factors important for APC development10, conserved across fetal 
(blue) and adult (red) spleen. 
 
Extended Data Fig. 3. Fetal APC populations cluster based on subset after the 
removal of tissue specific probes. a-d, Hierarchical clustering and PCA data 
before (a, c) and after (b, d) removal of tissue specific probes. It is clear from the 
hierarchical clustering (a) that there is strong tissue imprinting in the cells that 
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overwhelms subtype specificity. Upon the removal of tissue specific probes, cells 
now cluster based on subtype (b). Also clearly from the PCA plots (c, d), we can 
see that prior to tissue gene removal (c), PC1 is entirely determined by tissue. 
However, upon tissue specific probe removal (d), PC1 is now devoted to cell type. 
We identified these tissue-specific genes by finding DEGs between the pools of all 
cells from the different tissues (all spleen vs. all skin).  
 
Extended Data Fig. 4. Fetal and adult spleen cDC have similar phenotypes. a, 
b,  Characterization of cDC1 (green gate) and cDC2 (cyan gate) across adult and 
fetal spleen using CyTOF and one-Sense algorithm11. a, Representative gating 
strategy used to select input population (red gate) for One-Sense analysis from 
fetal (17wk EGA) and adult spleen samples. b, Representative data of fetal and 
adult spleen cDC analyzed using the one-Sense algorithm. The lineage dimension 
included CD1c and SIRPα as cDC2 markers, CD26 and CLEC9A as cDC1 
markers. The marker dimension includes all the other non-lineage markers of the 
CyTOF panel. Frequency heat maps of markers expression are displayed for both 
dimensions. The expression of markers by both adult and fetal spleen cDC1 
(green) and cDC2 (cyan) is highlighted with the dashed gates. Representative data 
from n=5 experiments.  
 
Extended Data Fig. 5. Phenotypic characterisation of fetal spleen, thymus, 
lung and gut cDC. a, Representative gating strategy used to select input 
population (red gate) for One-Sense analysis from fetal spleen, thymus, lung and 
gut (17wk EGA). b, Characterization of cDC1 (green gate) and cDC2 (cyan gate) 
across fetal lung, spleen, thymus and gut using CyTOF and one-Sense algorithm11. 
The lineage dimension included CD1c and SIRPα as cDC2 markers, CD26 and 
CLEC9A as cDC1 markers. The marker dimension includes all the other non-
lineage markers of the CyTOF panel. Frequency heat maps of markers expression 
are displayed for both dimensions. The expression of markers by fetal cDC1 
(green) and cDC2 (cyan) subsets are highlighted with the dashed gates. 
Representative data from n=5 experiments. c, Histograms displaying surface 
markers differentially expressed across fetal organs (17 wk EGA) but conserved 
from fetus to adult. The histograms are generated from CyTOF data (generated as 
described above). Data is representative of n=5 experiments. d, Fetal cDC1 (green 
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gate) and cDC2 (blue gate) populations were identified within each organ based on 
their CD26 and CD1c expression (top panel) by flow cytometry analysis. Using 
the gates in the top panel to select fetal cDC1 (green contours) and cDC2 (blue 
contours), intracellular expression of IRF8 and IRF4 was determined by flow 
cytometry. Representative data. n=3. 
 
Extended Data Fig. 6. Fetal cDC migrate to lymph nodes. a, Representative 
plot of CD14+ cells (red gate), cDC1 (green gate) and cDC2 (blue gate) identified 
within the MLN-resident (Res) DC gate (top panel) and migratory (Mig) DC gate 
(bottom panel), from a 16wk EGA sample. b, Abundance of cDC1 and cDC2 
plotted as a percentage of  the total cDC within the resident (left plot) and 
migratory (right plot) fraction within the MLN from 16-22wk EGA n=5. c, 
Histograms comparing the expression of activation markers by resident (pink) and 
migratory (orange) cDC1 and cDC2. n=3. d, RNA from fetal gut and MLN were 
analysed for the expression of CCL19 and CCL21 from early (13- 15wk EGA) and 
late (16-20wk EGA) samples. n=3. e, Detection of the proteins CCL19 and CCL21 
from lysed fetal gut cells by ELISA. f, Whole-mount immune-fluorescence 
microscopy of 17wk EGA fetal skin from 2 plains of view. Lymphatic vessels are 
labeled for LYVE-1 (red), APC are labeled for HLA-DR (green). White arrow 
indicates APC within lymphatic vessels. Scale bar represents 100µm (left image) 
and 150µm (right image). Representative image of n=3 experiments shown. g, 
Gating strategy used to identify CD14+ cells (red gate), cDC1 (green gate) and 
cDC2 (blue gate) within the supernatant from fetal skin explant left for 48 hours in 
culture and the digested remnant. Representative plots of n=3 experiments shown. 
 
Extended Data Fig. 7. Fetal cDC are sensitive to low concentrations of TLR 
agonist stimuli. a, Sort-purified fetal liver and adult spleen cDC2 were cultured 
with indicated TLR agonists for 18hrs. Cytokines produced were measured in the 
supernatants by Luminex assay. b, Heatmap of fetal and adult spleen APC 
populations of selected genes, including pathogen recognition receptors and co-
stimulatory molecules. Heat map shows the row-based z-score normalized gene 
expression intensities. 
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Extended Data Fig. 8. Fetal cDC promote Treg induction. a, b, Flow 
cytometry expression analysis of Tregs after 6 day co-culture of adult spleen T 
cells with fetal (n=5) or adult (n=4) spleen cDC2. a, b, The frequency of 
FOXP3+CD25+ Treg cells (a, red gate) and representative histograms showing 
intensity of CD127 and CTLA-4 expression by Tregs (red histograms) and 
respective isotype controls (grey histograms) are shown (b). c, Composite results 
showing the frequency of Treg cells plotted as percentage of CD4+ T cells, n≥4. d, 
Bar graph of proliferating CD8+ T cells after 6 days of adult spleen pan T cell co-
culture with fetal (black, n=4) or adult (grey, n=4) spleen cDC2. Proliferation was 
measured by CFSE dilution. e, Proliferation of isolated adult spleen CD8+ T cells, 
after co-culture with fetal spleen cDC2 for 6 days. Left, representative histograms 
showing CFSE dilution by CD8+ T cells on day 0 (grey histogram) compared to 
day 6 with (red histogram) or without (black histogram) CD4+ T cell depletion. 
Right, cumulative data (n=4). Bar graphs show mean±s.e.m. *P<0.05, **P<0.01, 
Mann-Whitney test. f, Fetal spleen cDC1 and cDC2 share immune-suppressive 
properties. Cytokine detected in co-culture supernatants (mean±s.e.m) after T cell 
co-culture with fetal cDC1 or cDC2 or adult cDC2 (n=5). Statistical significance 
represents comparisons between indicated conditions measured by one-way 
Anova, multiple comparisons test. * P<0.05, ** P<0.01, ***P<0.001, ns (not 
significant) P>0.05. 
 
 
Extended Data Fig. 9. Gene expression comparison between fetal and adult 
APC. a, Heatmap showing the row-based z-score normalized gene expression 
intensities of 3,909 differentially expressed genes  between fetal and adult APC. 
DEGs were identified using t-test with BH multiple testing corrected  p-value of 
<0.05. The genes and cell populations were clustered using Pearson correlation 
distance measure and Complete Linkage method. b, IngenuityTM Pathway 
Analysis (IPA) of the differentially-expressed genes (DEGs), >1.5 fold change, 
between fetal and adult APC. The bars indicate the p values (-log10) for pathway 
enrichment. The yellow squares indicate the ratio of the number of up- or down- 
regulated genes mapped to the enriched pathway, to the total number of molecules 
on that pathway represented by the dashed yellow line. The horizontal solid 
yellow line corresponds to the >1.5 fold change threshold. Red arrows highlight 
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pathways involved in DC:T cell interactions, black arrows highlight pathways 
associated with iNOS/TNF-α signaling. c, Heatmap of immune-modulatory genes 
involved in cellular metabolism, immune suppression and the iNOS/TNF-α 
signaling. Heat map shows the row-based z-score normalized gene expression 
intensities. d, e Microarray (d) and flow cytometry (e) data demonstrating 
arginase-2 expression by fetal (blue, n=11) and adult (red, n=7) APC subsets. 
Isotype control, grey histogram and square on scatterplot (n=7). Mean frequencies 
± s.e.m. f, Fetal and adult cDC2 arginase 2 expression is not mediated by TLR 
stimulation. Fetal liver and adult spleen cDC2 were sort-purified and stimulated 
with the indicated TLR agonists or DMSO control for 18hrs. cDC2 arginase 2 
(Arg 2) expression was measured by flow cytometry. Mean frequencies ± s.e.m. 
One-way Anova, multiple comparisons test. ** P<0.01 
 
Extended Data Fig. 10. Fetal cDC regulate T cell TNF-α  production.  
a, Ex-vivo  splenocyte T cell (bulk tissue cells) and enriched spleen T cell TNF-α 
production, representative plots of n=4.  b,  Ex-vivo  co-culture assay where fetal 
and adult splenocytes were cultured alone or at the indicated ratios of adult:fetal 
cells (n=3-4) for 6 days. TNF-α+ and Treg cells induction was determined by flow 
cytometry analysis. c – d, Scatterplots demonstrating the percentage of TNF-α+ T 
cells and Treg after the culture of splenocytes under the indicated conditions for 6 
days. n≥3, mean±s.e.m. Statistical significance represents comparisons between 
indicated conditions measured by one-way anova, multiple comparisons test. * 
P<0.05, **P<0.01, ***P<0.001, ns P>0.05. e – h, Scatterplots demonstrating the 
percentage (e, f) and absolute cell counts (g, h) of TNF-α+ T cells and Treg after 
o/n culture of adult spleen T cells alone (n=6)  or 6 day co-culture with fetal cDC2 
in the absence (n=6) or the presence of L-arginine (n=6), ABH (n=4) or BEC 
(n=5). Statistical significance represents comparisons between indicated 
conditions measured by one-way Anova, multiple comparisons test. * P<0.05, 
***P<0.001, ns P>0.05. i, Fetal DC arginase activity impacts T cell TNF-α 
production but not other pro-inflammatory cytokines. Cytokine detected in co-
culture supernatants after adult spleen T cell co-culture with fetal cDC2 in the 
absence (n=5) or presence of L-arginine (1mM) (n=5), BEC (30µM) (n=3), ABH 
(30µM) (n=5) for 6 days (mean ± s.e.m n≥3). Statistical significance represents 
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comparisons between indicated conditions measured by one-way Anova, multiple 
comparisons test. *P<0.05, **P<0.01 ns P>0.05. j, Adult spleen T cells were 
cultured overnight with the indicated of L-arginine, BEC and ABH (n=5). 
Representative flow cytometry of n=3 experiments. k, Cytokines detected in co-
culture supernatants after adult spleen T cells were cultured alone (in the absence 
of DC) for 6 days with or without L-arginine (1mM) (n=5), BEC (30µM) (n=3), 
ABH (30µM) (n=4) (mean ± s.e.m n≥3). l, m, Fetal spleen cDC (pooled cDC1 and 
cDC2) and adult spleen cDC2 were cultured alone or in combination at the 
indicated ratios with adult spleen T cells for 6 days.  T cell TNF-α production (k) 
and the expansion of Tregs (l) were assessed by flow cytometry. Statistical 
significance represents comparisons between indicated conditions measured by 
one-way Anova, multiple comparisons test. * P<0.05, ns P>0.05. Each data point 
in all the scatter plots represents an individual donor and experiment. 
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